Home/Filings/4/0001645113-22-000070
4//SEC Filing

Benaim Ely 4

Accession 0001645113-22-000070

CIK 0001645113other

Filed

Aug 2, 8:00 PM ET

Accepted

Aug 3, 4:44 PM ET

Size

5.1 KB

Accession

0001645113-22-000070

Insider Transaction Report

Form 4
Period: 2022-08-02
Benaim Ely
Chief Medical Officer
Transactions
  • Sale

    Ordinary Shares

    2022-08-02$69.66/sh437$30,44134,631 total
Footnotes (1)
  • [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1
  • filerCIK 0001632237

Filing Metadata

Form type
4
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 4:44 PM ET
Size
5.1 KB